These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 4270161)
1. [Preventive use of glycosides]. Jahrmärker H Internist (Berl); 1973 Jul; 14(7):306-12. PubMed ID: 4270161 [No Abstract] [Full Text] [Related]
2. [Rational prescription of cardiac stimulants]. Rietbrock N; Abshagen U; von Bergmann K; Kewitz H Dtsch Med J; 1972 Feb; 23(2):100-5. PubMed ID: 5017962 [No Abstract] [Full Text] [Related]
3. [Treatment of heart failure, with special consideration of iatrogenic complications]. Lüderitz B; Avenhaus H Munch Med Wochenschr; 1970 Oct; 112(40):1779-84. PubMed ID: 5536213 [No Abstract] [Full Text] [Related]
4. [Anesthesia and preoperative medication using cardiac glycosides]. Röse W Z Arztl Fortbild (Jena); 1975 Jul; 69(13):684-6. PubMed ID: 131421 [No Abstract] [Full Text] [Related]
5. [Cardiac glycoside therapy]. Michel D Fortschr Med; 1971 Aug; 89(24):917-21. PubMed ID: 4262966 [No Abstract] [Full Text] [Related]
6. [Quantitative studies on the therapeutic range of cardiac glycosides]. Diederen W; Kadatz R Arztl Forsch; 1970 May; 24(5):149-55. PubMed ID: 5538016 [No Abstract] [Full Text] [Related]
7. [Clinical pharmacology of cardiac glycosides]. Haustein KO Pol Tyg Lek; 1978 May; 33(20):817-20. PubMed ID: 673918 [No Abstract] [Full Text] [Related]
8. [Principles and directives for practical treatment with cardiac glycosides]. Dörffel EF Z Arztl Fortbild (Jena); 1971 Mar; 65(5):237-44. PubMed ID: 4997296 [No Abstract] [Full Text] [Related]
9. [Cardiac glycoside therapy]. Born H Folia Clin Int (Barc); 1969 Nov; 17(11):534-45. PubMed ID: 5803723 [No Abstract] [Full Text] [Related]
10. [Indications, contra-indications and dosage of cardiac glycosides controlled by plasma levels in the aged]. Hötter GJ Z Gerontol; 1987; 20(1):8-12. PubMed ID: 3577317 [TBL] [Abstract][Full Text] [Related]
11. [Reasons for prophylactic digitalization]. Savitskiĭ NN Klin Med (Mosk); 1974 Mar; 52(3):5-10. PubMed ID: 4466951 [No Abstract] [Full Text] [Related]
12. [Action mechanism of cardioactive glycosides in pathophysiologic conditions]. Bolte HD Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():19-27. PubMed ID: 611942 [No Abstract] [Full Text] [Related]
14. [Current status of the treatment with cardiac glycosides]. Pomerantsev VP; Kopsalova SM Sov Med; 1985; (7):44-8. PubMed ID: 4071234 [No Abstract] [Full Text] [Related]
15. [Use of unithiol for eliminating the toxic effects of cardiac glycosides]. Klykov NV Ter Arkh; 1966 Jul; 38(7):121-3. PubMed ID: 5999724 [No Abstract] [Full Text] [Related]
16. Complications of prophylactic digitalization in thoracic surgical patients. Juler GL; Stemmer EA; Connolly JE J Thorac Cardiovasc Surg; 1969 Sep; 58(3):352-60. PubMed ID: 5811020 [No Abstract] [Full Text] [Related]
17. [Rare heart rhythm disorders an an early symptom of glycoside intolerance]. Homola D; Klein KW; Srnová V; Zavrelová V Z Gesamte Inn Med; 1968 May; 23(10):293-7. PubMed ID: 5701143 [No Abstract] [Full Text] [Related]
18. [Preventive administration of cardiac glycosides]. Haslbeck M Munch Med Wochenschr; 1971 Dec; 113(51):1722-3. PubMed ID: 5172167 [No Abstract] [Full Text] [Related]
20. The role of the sugar component in cardiac glycosides on their action in patients with auricular fibrillation and congestive failure. Gold H; Kwit NT; Shane SJ; Dayrit C J Clin Pharmacol J New Drugs; 1969; 9(3):148-54. PubMed ID: 5255179 [No Abstract] [Full Text] [Related] [Next] [New Search]